Renaissance Technologies - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 242 filers reported holding ACCELERON PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q4 2020$4,759,000
-79.4%
37,200
-81.9%
0.01%
-78.3%
Q3 2020$23,092,000
+78.7%
205,207
+51.3%
0.02%
+109.1%
Q2 2020$12,919,000
-28.0%
135,600
-32.1%
0.01%
-35.3%
Q1 2020$17,938,000
+760.3%
199,600
+246.5%
0.02%
+325.0%
Q3 2016$2,085,000
+2.5%
57,600
-10.4%
0.00%
-20.0%
Q2 2015$2,034,00064,3000.01%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 1,505,012$204,095,00039.96%
Foresite Capital Management III, LLC 108,630$14,731,00012.94%
Avoro Capital Advisors LLC 3,000,000$406,830,0007.03%
Octagon Capital Advisors LP 112,363$15,238,0005.74%
Artal Group S.A. 1,400,000$189,854,0003.36%
Eversept Partners, LP 241,981$32,815,0432.47%
NWI MANAGEMENT LP 200,000$27,122,0002.26%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 60,500$8,199,0002.17%
Affinity Asset Advisors, LLC 45,000$6,102,0002.07%
Parkman Healthcare Partners LLC 62,780$8,514,0001.98%
View complete list of ACCELERON PHARMA INC shareholders